The abstract is read at the publisher; the summary is JClub's.
Folic acid prophylaxis ameliorates Toxoplasma gondii soluble tachyzoite antigen–induced vascular injury in murine models and human vascular organoids by suppressing CD36.
- Why it matters: Pathogen-derived antigens may directly damage blood vessels, but the endothelial mechanisms and therapeutic leverage remain unclear.
- What they did: Using murine models and human pluripotent stem cell-derived vascular organoids, the study tested T. gondii infection or soluble tachyzoite antigens and assessed CD36-dependent antigen uptake and autophagy-lysosomal pathway disruption, then evaluated prophylactic folic acid.
- The result: Folic acid reduced CD36 expression, limited antigen uptake, and attenuated ALP hyperactivation, preserving vascular integrity at molecular, structural, and metabolic levels.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.